921
Views
0
CrossRef citations to date
0
Altmetric
Physical Medicine & Rehabilitation

Multifaceted associations between walking performance, physical fitness, extremity function, health status, and depression in individuals with COPD

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2338248 | Received 18 Oct 2023, Accepted 06 Mar 2024, Published online: 08 Apr 2024

References

  • Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):1–11. doi: 10.1016/s2213-2600.(21)00511-7.
  • Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6(7):535–544. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30100-0/fulltext (accessed February 24, 2024). doi: 10.1016/S2213-2600(18)30100-0.
  • Aldhahi MI, Baattaiah BA, Nazer RI, et al. Impact of psychological factors on functional performance among patients with chronic obstructive pulmonary disease. Int J Environ Res Public Health. 2023;20(2):1285. doi: 10.3390/ijerph20021285.
  • Thomas AJ. Chronic obstructive pulmonary disease: the contribution of skeletal muscle dysfunction to exercise intolerance. Phy Ther Rev. 2006;11(1):62–66. doi: 10.1179/108331906X98912.
  • Wada JT, Borges-Santos E, Porras DC, et al. Effects of aerobic training combined with respiratory muscle stretching on the functional exercise capacity and thoracoabdominal kinematics in patients with COPD: a randomized and controlled trial. Int J Chron Obstruct Pulmon Dis. 2016;11:2691–2700. doi: 10.2147/copd.S114548.
  • McDougall J, Wright V, Rosenbaum P. The ICF model of functioning and disability: incorporating quality of life and human development. Dev Neurorehabil. 2010;13(3):204–211. doi: 10.3109/17518421003620525.
  • Stucki A, Stoll T, Cieza A, et al. ICF core sets for obstructive pulmonary diseases. J Rehabil Med. 2004;36(44 Suppl):114–120. doi: 10.1080/16501960410016794.
  • Wu M-F, Teng C-M, Kuo T-H, et al. A pervasive pulmonary function estimation system with Six-Minute walking test. Biosensors . 2022;12(10):824. https://www.mdpi.com/2079-6374/12/10/824 (accessed March 1, 2024). doi: 10.3390/bios12100824.
  • Celli B, Tetzlaff K, Criner G, et al. The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification consortium. Am J Respir Crit Care Med. 2016;194(12):1483–1493. doi: 10.1164/rccm.201508-1653OC.
  • Souto-Miranda S, Antão J, Rodrigues G, et al. Cut-off of the one-minute sit-to-stand test to detect functional impairment in people with chronic obstructive pulmonary disease. Respir Med. 2022;199:106892. doi: 10.1016/j.rmed.2022.106892.
  • Zhang Q, Li YX, Li XL, et al. A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:2833–2839. doi: 10.2147/copd.S173509.
  • Wüst RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis. 2007;2:289–300.
  • Abdulai RM, Jensen TJ, Patel NR, et al. Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(4):433–449. doi: 10.1164/rccm.201703-0615CI.
  • Morais N, Cruz J, Marques A. Posture and mobility of the upper body quadrant and pulmonary function in COPD: an exploratory study. Braz J Phys Ther. 2016;20(4):345–354. doi: 10.1590/bjpt-rbf.2014.0162.
  • Meijer K, Annegarn J, Lima Passos V, et al. Characteristics of daily arm activities in patients with COPD. Eur Respir J. 2014;43(6):1631–1641. doi: 10.1183/09031936.00082513.
  • Vaes AW, Wouters EFM, Franssen FME, et al. Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects. Chest. 2011;140(4):970–979. doi: 10.1378/chest.10-3005.
  • NS, Correia JM, Oliveira, DR, Fernandes, et al. Validity, reproducibility, and minimal detectable difference of the functional upper extremity function test - simplified version - for adults with moderate-severe asthma and COPD. Respir Care. 2023;68(8):1058–1066. doi: 10.4187/respcare.10464.
  • Ebadi Z, Goërtz YMJ, Van Herck M, et al. The prevalence and related factors of fatigue in patients with COPD: a systematic review. Eur Respir Rev. 2021;30(160):200298. doi: 10.1183/16000617.0298-2020.
  • von Leupoldt A, Taube K, Lehmann K, et al. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011;140(3):730–736. doi: 10.1378/chest.10-2917.
  • Fleehart S, Fan VS, Nguyen HQ, et al. Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study. Int J Chron Obstruct Pulmon Dis. 2015;10:1321–1329. doi: 10.2147/copd.S65507.
  • Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am J Respir Crit Care Med. 2023;207(7):819–837. doi: 10.1164/rccm.202301-0106PP.
  • Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi: 10.1164/rccm.201908-1590ST.
  • ATS Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi: 10.1164/ajrccm.166.1.at1102.
  • Cote CG, Casanova C, Marín JM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008;31(3):571–578. https://erj.ersjournals.com/content/31/3/571.short (accessed February 24, 2024). doi: 10.1183/09031936.00104507.
  • Torres JPD, Casanova C, Cote CG, et al. Six-Minute walking distance in women with COPD. Int J Chron Obstruct Pulmon Dis. 2011;8(4):300–305. doi: 10.3109/15412555.2011.589870.
  • Albarrati A, Hazazi I, Alnahdi AH, et al. Psychometric properties of the Arabic version of duke activity status index in patients with chronic obstructive pulmonary disease. Disabil Rehabil. 2023;45(4):717–722. doi: 10.1080/09638288.2022.2037748.
  • El Rhazi K, Nejjari C, Benjelloun MC, et al. Validation of the St. George’s respiratory questionnaire in patients with COPD or asthma in Morocco. Int J Tuberc Lung Dis. 2006;10(11):1273–1278.
  • AlHadi AN, AlAteeq DA, Al-Sharif E, et al. An Arabic translation, reliability, and validation of patient health questionnaire in a Saudi sample. Ann Gen Psychiatry. 2017;16(1):32. doi: 10.1186/s12991-017-0155-1.
  • Aljathlani MF, Alshammari MO, Alsuwaygh MA, et al. Cross-cultural adaptation and validation of the Arabic version of the upper extremity functional index. Disabil Rehabil. 2022;44(19):5656–5662. doi: 10.1080/09638288.2021.1947396.
  • Alnahdi AH, Albarrati A. The Arabic version of the lower extremity functional scale is a reliable and valid measure of activity limitation in people with chronic obstructive pulmonary disease. Disabil Rehabil. 2022;44(26):8487–8492. doi: 10.1080/09638288.2021.2019842.
  • Kohansal R, Martinez-Camblor P, Agustí A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3–10. doi: 10.1164/rccm.200901-0047OC.
  • Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010;104(6):849–857. doi: 10.1016/j.rmed.2009.12.007.
  • O’Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008;105(2):753–755. doi: 10.1152/japplphysiol.90336.2008b.
  • Sanseverino MA, Pecchiari M, Bona RL, et al. Limiting factors in walking performance of subjects with COPD. Respir Care. 2018;63(3):301–310. doi: 10.4187/respcare.05768.
  • Lange P, Ahmed E, Lahmar ZM, et al. Natural history and mechanisms of COPD. Respirology. 2021;26(4):298–321. doi: 10.1111/resp.14007.
  • Driver CN, Novotny PJ, Benzo RP. Differences in sedentary time, light physical activity, and steps associated with better COPD quality of life. Chronic Obstr Pulm Dis. 2022;9(1):34–44. doi: 10.15326/jcopdf.2021.0230.
  • Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121(9):789–796. doi: 10.1016/j.amjmed.2008.04.030.
  • Ehsani H, Mohler MJ, Golden T, et al. Upper-extremity function prospectively predicts adverse discharge and all-cause COPD readmissions: a pilot study. Int J Chron Obstruct Pulmon Dis. 2019;14:39–49. doi: 10.2147/COPD.S182802.
  • Pan L, Guo YZ, Yan JH, et al. Does upper extremity exercise improve dyspnea in patients with COPD? A meta-analysis. Respir Med. 2012;106(11):1517–1525. doi: 10.1016/j.rmed.2012.08.002.
  • Gosselink RIK, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153(3):976–980. doi: 10.1164/ajrccm.153.3.8630582.
  • Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD, 2014).
  • Antonucci R, Berton E, Huertas A, et al. Exercise physiology in COPD. Monaldi Arch Chest Dis. 2003;59(2):134–139.
  • Di Marco F, Terraneo S, Roggi MA, et al. Physical activity impairment in depressed COPD subjects. Respir Care. 2014;59(5):726–734. doi: 10.4187/respcare.02848.
  • Annegarn J, Spruit MA, Savelberg HHCM, et al. Differences in walking pattern during 6-Min walk test between patients with COPD and healthy subjects. PLOS One. 2012;7(5):e37329. doi: 10.1371/journal.pone.0037329.
  • Rejbi IBC, Trabelsi Y, Chouchene A, et al. Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects. Int J Chron Obstruct Pulmon Dis. 2010;5:209–215. doi: 10.2147/copd.s7955.
  • Spruit MA, Polkey MI, Celli B, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012;13(3):291–297. doi: 10.1016/j.jamda.2011.06.009.
  • Sánchez-Martínez MP, Bernabeu-Mora R, Martínez-González M, et al. Stability and predictors of poor 6-min walking test performance over 2 years in patients with COPD. JCM. 2020;9(4):1155. doi: 10.3390/jcm9041155.
  • Lee J, Nguyen HQ, Jarrett ME, et al. Effect of symptoms on physical performance in COPD. Heart Lung. 2018;47(2):149–156. doi: 10.1016/j.hrtlng.2017.12.007.
  • Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(6):1395–1399. doi: 10.1164/ajrccm.163.6.2003172.
  • Wegner RE, Jörres RA, Kirsten DK, et al. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J. 1994;7(4):725–729. doi: 10.1183/09031936.94.07040725.
  • Louvaris Z, Kortianou EA, Spetsioti S, et al. Intensity of daily physical activity is associated with Central hemodynamic and leg muscle oxygen availability in COPD. J Appl Physiol 2013;115(6):794–802. doi: 10.1152/japplphysiol.00379.2013.
  • Nishiyama O, Taniguchi H, Kondoh Y, et al. The effectiveness of the visual analogue scale 8 in measuring health-related quality of life for COPD patients. Respir Med. 2000;94(12):1192–1199. doi: 10.1053/rmed.2000.0950.
  • Haave E, Hyland ME, Skumlien S. The relation between measures of health status and quality of life in COPD. Chron Respir Dis. 2006;3(4):195–199. doi: 10.1177/1479972306070069.
  • Fazekas-Pongor V, Fekete M, Balazs P, et al. Health-related quality of life of COPD patients aged over 40 years. PhysInt. 2021;108(2):261–273. doi: 10.1556/2060.2021.00017.
  • Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi: 10.1016/S0140-6736.(07)61382-8.
  • Beekman E, Mesters I, Hendriks EJ, et al. Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial. BMC Pulm Med. 2014;14(1):71. doi: 10.1186/1471-2466-14-71.
  • Miranda EF, Malaguti C, Marchetti PH, et al. Upper and lower limb muscles in patients with COPD: similarities in muscle efficiency but differences in fatigue resistance. Respir Care. 2014;59(1):62–69. doi: 10.4187/respcare.02439.
  • Dourado VZ, Antunes LCDO, Tanni SE, et al. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest. 2006;129(3):551–557. doi: 10.1378/chest.129.3.551.
  • Biswas D. Occurrence of anxiety and depression among stable COPD patients and its impact on functional capability. JCDR. 2017;11(2):OC24–OC27. doi: 10.7860/JCDR/2017/24203.9393.
  • Al-Shair K, Dockry R, Mallia-Milanes B, et al. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med. 2009;103(10):1572–1579. doi: 10.1016/j.rmed.2008.11.021.
  • Hynninen KMJ, Breitve MH, Wiborg AB, et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005;59(6):429–443. doi: 10.1016/j.jpsychores.2005.04.007.
  • Hill K, Geist R, Goldstein RS, et al. Anxiety and depression in end-stage COPD. Eur Respir J. 2008;31(3):667–677. doi: 10.1183/09031936.00125707.
  • Hogea S, Tudorache E, Fildan AP, et al. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J. 2020;14(3):183–197. doi: 10.1111/crj.13129.
  • Norwood R, Balkissoon R. Current perspectives on management of Co-Morbid depression in COPD. Chr Obstruct Pulmonary Dis. 2005;2(1):185–193. doi: 10.1081/COPD-200050740.